If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 121 - 130 of 275
Neurally Decoding Imagined Language in Severe Expressive Aphasia
Objective
Neurally Decoding Imagined Language in Severe Expressive Aphasia
Protocol No
NEURO-IIT-ANDERSON-DIL
Cognitive Functioning and Gender-Affirming Hormones in Transgender Adults
Objective
Cognitive Functioning and Gender-Affirming Hormones in Transgender Adults
Protocol No
NEURO-IIT-CORRERO-GAHT-COG
Categories
Behavioral Assessment of Semantic Representation Data
Objective
Behavioral Assessment of Semantic Representation Data
Protocol No
NEURO-IIT-LF-BASR
Examination of Motor Unit Alterations in Acute and Subacute Stroke
Objective
Motor Unit Alterations in Acute and Subacute Stroke
Protocol No
NEURO-IIT-LI-MOTOR-UNIT-ALT
Categories
A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia
Objective
HD-tDCS for Phonological Impairment in Aphasia
Protocol No
NEURO-IIT-PILLAY-ALF-TDCS
Behavioral Aphasia Treatments
Objective
Behavioral Aphasia Treatments
Protocol No
NEURO-IIT-PSB-BAT
Categories
TES To Remediate Phonological Impairments After Stroke
Objective
TES for Language Impairment
Protocol No
NEURO-IIT-SHAH-TES
Categories
Gut-oral-microbiota-brain Axis in Adults at Risk for AD
Objective
SCD Microbiome Project
Protocol No
NEURO-IIT-UMFLEET-SCDMICROB
A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of Batoclimab Treatment in Adult Participants With Active Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Objective
Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
Protocol No
NEURO-IMVT-1401-2401-CIDP
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lenrispodun as Adjunctive Therapy in the Treatment of Patients with Motor Fluctuations due to Parkinson's Disease
Objective
Lenrispodun Adjunctive Therapy in Parkinsons Disease
Protocol No
NEURO-ITI-214-202-LENRISPODUN